Committee Hearings, Extending the Patent Term for Drugs Undergoing FDA Review During the Enactment of Hatch-Waxman


This page contains testimony given before Congressional committees related to this issue. Note that many organizations giving testimony before committees also have statements and information available on their own webpages. That material is available under organizational statements.

This page contains all abstracts from hearings, but only selected transcripts released electronically by the relevant committee.


Abstracts:


Testimony: